NGL Fine-Chem Limited is planning a greenfield development at Tarapur with a 50 percent capacity expansion.
According to sources, Rs 140 crore is the estimated capex, which will be paid for with debt and internal accrual. The company has spent Rs 7 crore on capital expenditures so far. The plant is now undergoing civil construction, and commercial operation is anticipated in FY24. The implementation has currently slowed significantly due to the high cost of commodities.
Pharmaceuticals and intermediates for use in human and veterinary health are produced by NGL Fine-Chem Ltd. The company offers dependable and adaptable custom pharmaceutical manufacturing to a range of international businesses.
